Spinal cord stimulator litigation changed materially in 2026, and a useful page now has to begin with the manufacturer. Boston Scientific cases are being coordinated in a federal MDL, while claims involving other manufacturers do not automatically belong to that same proceeding. At the same time, the FDA has continued to publish device-specific recalls and safety actions involving spinal cord stimulation systems.

For someone who has been injured, that means “I have a spinal cord stimulator” is only the first fact. The device maker, model, implant date, lead system, programming history, alleged malfunction, medical response, and any revision or explant procedure can all change the legal analysis.

There is not one universal spinal cord stimulator lawsuit

On June 5, 2026, the Judicial Panel on Multidistrict Litigation created MDL No. 3181 for federal product-liability cases involving Boston Scientific spinal cord stimulators and assigned the proceeding to Judge Josephine L. Staton in the Central District of California. The Panel did not create one industrywide MDL covering every SCS manufacturer.

That distinction is important. A patient with a Boston Scientific device may face a different procedural path from someone with an Abbott, Medtronic, Nevro, or other system. A 2026 law-firm page that treats every brand as one national “class action” would blur the actual litigation posture.

Current MDL documents are available through the federal court. Central District of California: MDL 3181 Pretrial Order No. 3

A September 2026 FDA recall shows why the lead system matters

On September 3, 2026, the FDA posted a recall involving unused Boston Scientific Infinion CX spinal cord stimulator leads and identified it as the most serious type of recall. Boston Scientific reported that mechanical stress at the anchor site may lead to high impedance measurements or lead fractures, which may result in inadequate stimulation and additional intervention, including lead replacement or explant.

FDA reported 1,081 serious injuries and no deaths associated with the issue as of May 27, 2026. The agency also stated that the action applies to unused affected leads and does not require additional monitoring beyond routine clinical follow-up for devices already implanted. Both parts of that statement matter. The recall is important evidence of a specific device issue, but it should not be used to tell every implanted patient that the device has been recalled out of their body or that an injury has automatically been caused by the lead.

The implant card can be more useful than a generic symptom list

A spinal cord stimulator system can include an implantable pulse generator, one or more leads, a controller, charger, and related software or accessories. The implant card, operative report, and device records can identify the manufacturer, model, serial number, and unique device identifier. Those details can show whether a particular recall, safety communication, or lawsuit actually concerns the patient’s system.

That is why a device-specific review is stronger than a page that simply lists every complication ever reported with spinal stimulation. The legal question is not whether a symptom appears somewhere on the internet. It is whether the patient’s medical and device evidence supports a defect, warning, manufacturing, or other viable product-liability theory under the applicable law.

What kinds of complications warrant a closer review?

Palmer Law reviews serious complications after implantation, including worsening pain, painful electrical or burning sensations, lead fracture or migration, and other significant neurological or autonomic problems. Some people may also undergo revision surgery or explantation because the system failed, moved, could not be programmed as intended, or produced intolerable effects.

Poor pain relief by itself does not necessarily establish a defective-device claim. Chronic pain treatment can fail for many reasons. A stronger review asks what the device actually did, whether clinicians documented a hardware or programming problem, what imaging or interrogation showed, whether there was an FDA action involving the specific component, and why an additional surgery became necessary.

The records that can separate one SCS claim from another

  • Implant card, device sticker, or records identifying the manufacturer and model.
  • Implantation and trial-procedure operative reports.
  • Programming, interrogation, charging, or device-representative records.
  • Imaging showing lead position, migration, fracture, or other hardware concerns.
  • Pain-management and neurology records documenting the before-and-after condition.
  • Revision, lead-replacement, or explant operative reports and the reason for the procedure.
  • Any notice from a physician or manufacturer concerning a recall, field correction, or device advisory.

Palmer’s “after 2016” screen is an intake criterion, not a legal deadline

Palmer Law’s current screening criteria focus on people implanted after 2016 and include Abbott, Boston Scientific, Medtronic, Nevro, and other manufacturers. That may be a practical case-screening choice, but it should not be presented as a statute, a universal eligibility rule, or a statement that older devices can never support a claim.

The same is true of symptom lists. Palmer can use its current screening criteria to decide which matters to investigate, while the public page explains that device identity, medical evidence, manufacturer-specific litigation, and state-law deadlines require individual review.

Does MDL 3181 include every spinal cord stimulator?

No. The current federal MDL is specifically styled In re: Boston Scientific Corporation Spinal Cord Stimulator Products Liability Litigation. Claims involving other manufacturers may proceed separately or be affected by later court orders. The status should be checked again before publication and whenever this page is refreshed.

Request a spinal cord stimulator case review

If you experienced painful shocks, lead problems, worsening pain, a documented device malfunction, or revision or removal surgery after a spinal cord stimulator implant, Palmer Law can review the device information and medical timeline. Palmer can then explain whether the matter fits the firm’s current criteria and, if appropriate, whether the firm can assist directly or coordinate with trusted legal counsel.